-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Friday's After-Market Session
Share
Listen to the news

Gainers

  • Theriva Biologics (AMEX:TOVX) shares moved upwards by 47.5% to $0.38 during Friday's after-market session. The company's market cap stands at $11.5 million.
  • Psyence Biomedical (NASDAQ:PBM) stock increased by 16.31% to $8.84. The company's market cap stands at $6.0 million.
  • VivoSim Labs (NASDAQ:VIVS) stock rose 6.21% to $1.71. The company's market cap stands at $4.3 million.
  • Cadrenal Therapeutics (NASDAQ:CVKD) stock rose 5.74% to $5.52. The market value of their outstanding shares is at $11.3 million.
  • Zentalis Pharmaceuticals (NASDAQ:ZNTL) shares increased by 5.38% to $4.89. The market value of their outstanding shares is at $356.0 million.
  • Basel Medical Group (NASDAQ:BMGL) shares rose 5.06% to $0.6. The company's market cap stands at $11.2 million.

Losers

  • SBC Medical Group Holding (NASDAQ:SBC) stock fell 11.4% to $3.98 during Friday's after-market session. The company's market cap stands at $453.3 million.
  • VolitionRX (AMEX:VNRX) shares fell 8.79% to $0.16. The market value of their outstanding shares is at $23.8 million.
  • Lunai Bioworks (NASDAQ:LNAI) shares declined by 8.23% to $0.32. The company's market cap stands at $11.0 million.
  • CapsoVision (NASDAQ:CV) stock declined by 7.66% to $5.55. The market value of their outstanding shares is at $269.1 million.
  • Akanda (NASDAQ:AKAN) stock declined by 7.63% to $3.27. The company's market cap stands at $1.7 million.
  • Forum Markets (NASDAQ:FRMM) stock declined by 6.76% to $4.0. The market value of their outstanding shares is at $48.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending